Elanco Animal Health Inc (NYSE:ELAN) shares, rose in value on Thursday, April 25, with the stock price down by -3.04% to the previous day’s close as strong demand from buyers drove the stock to $12.90.
Actively observing the price movement in the recent trading, the stock is buoying the session at $13.31. Referring to stock’s 52-week performance, its high was $16.88, and the low was $7.88. On the whole, ELAN has fluctuated by -18.79% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 4.5B, with a low estimate of 1.17B and a high estimate of 1.18B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.17B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ELAN’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ELAN currently trading nearly -11.68% and -16.60% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.13, while the 7-day volatility ratio is showing 4.59% which for the 30-day chart, stands at 3.06%. Furthermore, Elanco Animal Health Inc (ELAN)’s beta value is 1.34, and its average true range (ATR) is 0.49.
A comparison of Elanco Animal Health Inc (ELAN) with its peers suggests the former has fared considerably weaker in the market. ELAN showed an intraday change of -3.04% in today’s session so far, and over the past year, it grew by 38.32%%.
Data on historical trading for Elanco Animal Health Inc (NYSE:ELAN) indicates that the trading volumes over the past 3 months, they’ve averaged 4.16 million. According to company’s latest data on outstanding shares, there are 492.85 million shares outstanding.
Nearly 0.97% of Elanco Animal Health Inc’s shares belong to company insiders and institutional investors own 98.16% of the company’s shares. The stock has fallen by -13.39% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ELAN stock heading into the next quarter.
